Results 281 to 290 of about 258,151 (309)

Prostate-Specific Antigen Density and Age-Specific Prostate-Specific Antigen Values: The Solution of Prostate Cancer Screening?

European Urology, 1995
The results of 225 systematic prostate biopsies from 1992 to 1993 were evaluated retrospectively. The parameters prostate-specific antigen (PSA) density and age-specific PSA values were compared with digital rectal examination, transrectal ultrasound, and PSA as single parameters and possible combinations.
R, Paul, J, Breul, R, Hartung
openaire   +2 more sources

Prostate-specific antigen in management of prostatic carcinoma

Urology, 1989
In 1979, Wang and associates isolated prostate-specific antigen (PSA). Only recently, however, has the clinical importance of this new tumor marker been recognized. It is now widely accepted that PSA represents a significantly more effective tumor marker than prostatic acid phosphatase (PAP).
M K, Brawer, P H, Lange
openaire   +2 more sources

Screening for Prostatic Carcinoma with Prostate Specific Antigen

Journal of Urology, 1992
Prostate specific antigen (PSA), neutral serine protease secreted exclusively by prostatic epithelial cells, has a number of applications in the management of men with prostatic carcinoma. While it is widely recognized that elevated PSA correlates with the presence of carcinoma, little data exist regarding the use of PSA as the initial test in the ...
M K, Brawer, M P, Chetner, J, Beatie, D M, Buchner, R L, Vessella, P H, Lange   +5 more
openaire   +2 more sources

Prostate-specific antigen as a marker of prostate disease

Virchows Archiv, 2000
Serum prostate markers, in particular prostate-specific antigen (PSA), have truly revolutionised all aspects of the management of men with prostatic carcinoma (PCa), the most important application being related to its early detection and screening. Several studies have shown the clinical utility of PSA levels for staging patients with PCa, especially ...
R, Montironi, R, Mazzucchelli, F, Algaba, D G, Bostwick, A, Krongrad   +4 more
openaire   +2 more sources

Prostate cancer in the era of prostate-specific antigen

Current Opinion in Oncology, 1995
The number of cases of prostate cancer diagnosed increased by 15% in the past year. This trend is likely to continue as prostate-specific antigen testing was approved for screening during the past year. The result is that mroe patients are being diagnosed at an earlier and presumably curable stage, although the long-term impact on survival has not been
H I, Scher, S, Fossa
openaire   +2 more sources

Prostate‐specific antigen

Histopathology, 1988
E, Herman, E, Elfont, T, Boenisch
openaire   +2 more sources

Prostatic Specific Antigen

British Journal of Urology, 1991
openaire   +2 more sources

Prostate‐specific membrane antigen

British Journal of Urology, 1998
B H, Maraj, P, Whelan, A F, Markham
openaire   +2 more sources

Prostate-specific antigen: current status

Ca-A Cancer Journal for Clinicians, 1999
Michael K Brawer
exaly  

Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer

Ca-A Cancer Journal for Clinicians, 2016
Baris Turkbey, Anna M Brown, Sandeep Sankineni   +2 more
exaly